EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access

Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway

Nishant Patidar, Archana M Navale, Nitesh Parsaila, Dinesh Sharma, Prachi Nahar, Sagar Shinde, Nilay Solanki, Ajay Shelke

American Journal of Translational Research · 2025 · 17 (4) · 2396-2410

DOI: 10.62347/mobz7773 ↗

At a glance

Übersichtsarbeit in American Journal of Translational Research, 2025. Written by Nishant Patidar and 7 co-authors. Institution: Department of Pharmacology, Parul Institute of Pharmacy, Parul University Limda, Vadodara, Gujarat, India. Cited 6 times so far (Crossref). The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Nicotine addiction is a complex phenomenon entwined with intricate mechanisms within the nicotine receptor pathway. This review offers an insightful exploration of this multifaceted landscape, delving into the interplay between nicotinic acetylcholine receptors (nAChRs) and their pivotal role in neurotransmission. The structural and functional aspects of nAChRs, their distribution within the peripheral and central nervous systems, and their involvement in modulating diverse signalling cascades are reviewed. The clinical implications of nicotine addiction and the challenges in smoking cessation are also explored. Nicotine Replacement Therapy (NRT) drugs, designed to alleviate withdrawal symptoms and aid in smoking cessation, are critically evaluated. This article synthesizes current research findings on the efficacy, safety, and limitations of various NRT modalities. Furthermore, emerging pharmacotherapeutic strategies and novel molecules aimed at optimizing NRT outcomes are discussed. The potential of leveraging a deeper understanding of the nicotine receptor pathway to develop more targeted and efficacious NRT interventions is emphasized. The exploration of adjunct therapies and combination approaches to enhance the success rates of smoking cessation is also addressed. Through a synthesis of preclinical and clinical evidence, this article aims to provide a comprehensive resource for researchers, clinicians, and policymakers working towards advancing the field of nicotine addiction treatment. As the global effort to combat tobacco-related health challenges intensifies, a nuanced understanding of the nicotine receptor pathway and its therapeutic implications becomes increasingly imperative.

Subjects

Author keywords

CB1 receptor antagonistCRF1 receptor pathwaybupropionneuropharmacologyreward pathwayvarenicline

Authors and institutions

  • Department of Pharmacology, Parul Institute of Pharmacy, Parul University Limda, Vadodara, Gujarat, India.
  • Department of Pharmacology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology Changa, Gujarat, India.

Cite

APA

Patidar, N., Navale, A. M., Parsaila, N., Sharma, D., Nahar, P., Shinde, S., Solanki, N., & Shelke, A. (2025). Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway. American Journal of Translational Research, 17(4), 2396-2410. https://doi.org/10.62347/mobz7773

Vancouver

Patidar N, Navale AM, Parsaila N, Sharma D, Nahar P, Shinde S, et al. Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway. American Journal of Translational Research. 2025;17(4):2396-2410. doi:10.62347/mobz7773

BibTeX
@article{Patidar2025,
  author = {Patidar, Nishant and Navale, Archana M and Parsaila, Nitesh and Sharma, Dinesh and Nahar, Prachi and Shinde, Sagar and Solanki, Nilay and Shelke, Ajay},
  title = {Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway},
  journal = {American Journal of Translational Research},
  year = {2025},
  volume = {17},
  number = {4},
  pages = {2396--2410},
  doi = {10.62347/mobz7773}
}
Start for free →